Proteomics Shared Resource (PSR) The goal of the Proteomics Shared Resource (PSR) is to enable University of Arizona Cancer Center (UACC) investigators to identify and characterize proteins and peptides and their modifications using modern proteomics methods. The PSR provides twenty distinct proteomics services that enable the systematic analysis of protein identification and characterization, including quantification and mapping modifications, via state-of-the-art modern mass spectrometry and peripheral instrumentation. PSR equipment includes an array of proteomics instrumentation including 2D and 3D quadrupole ion traps, hybrid mass analyzers (Waters QTOF Premier and the AB Sciex 4000 QTRAP), an AB Sciex triple quadruple mass analyzer and MALDI-TOF mass spectrometer, and a linear quadrupole ion trap Orbitrap Velos high-resolution and high-accuracy mass spectrometer system with CID/HCD/ETD. All mass analyzers are full LC-MS/MS systems, with the exception of the MALDI-TOF system. A comprehensive set of proteomics services are offered to UACC members at very affordable rates. Free-of-charge unlimited assistance and consultation with experimental design, planning, data mining, and data interpretation are also offered to UACC members. The PSR staff provides training for users when requested.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023074-36
Application #
9149091
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
36
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Boese, Cody J; Nye, Jonathan; Buster, Daniel W et al. (2018) Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. Mol Biol Cell 29:2874-2886
Knudsen, Erik S; Balaji, Uthra; Mannakee, Brian et al. (2018) Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut 67:508-520
Doane, Cynthia J; Patil, Karuna; Hoffman, Emely A et al. (2018) Supernumerary Incisors in CB6F1 Mice Conditioned with Chemotherapy and Total Body Irradiation before Bone Marrow Transplantation. Comp Med 68:349-352
Sohail, Atif; Mushtaq, Adeela; Iftikhar, Ahmad et al. (2018) Emerging immune targets for the treatment of multiple myeloma. Immunotherapy 10:265-282
Lent, Adrienne B; O'Connor, Patrick A; Reikowsky, Ryan C et al. (2018) Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study. BMC Public Health 18:1001
Bea, J W; Hsu, C-H; Blew, R M et al. (2018) Use of iDXA spine scans to evaluate total and visceral abdominal fat. Am J Hum Biol 30:
Zaim, Samir Rachid; Li, Qike; Schissler, A Grant et al. (2018) Emergence of pathway-level composite biomarkers from converging gene set signals of heterogeneous transcriptomic responses. Pac Symp Biocomput 23:484-495
Bulkley, Joanna E; McMullen, Carmit K; Grant, Marcia et al. (2018) Ongoing ostomy self-care challenges of long-term rectal cancer survivors. Support Care Cancer 26:3933-3939
Kelly, K R; Espitia, C M; Zhao, W et al. (2018) Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia 32:230-233
Kobes, Joseph E; Georgiev, George I; Louis, Anthony V et al. (2018) A Comparison of Iron Oxide Particles and Silica Particles for Tracking Organ Recellularization. Mol Imaging 17:1536012118787322

Showing the most recent 10 out of 1336 publications